Title: Juergen Scharner: Innovator in RNA Therapeutics
Introduction: Juergen Scharner is an accomplished inventor based in Arlington, MA (US). He currently works at Stoke Therapeutics, Inc., where he focuses on developing innovative solutions in the field of RNA therapeutics. Despite having no granted patents to his name, his contributions to the field are noteworthy.
Latest Patent Applications: Juergen Scharner has filed several patent applications that highlight his research and innovative approaches. One of his latest applications is titled "Antisense Oligomers for Treatment of Non-Sense Mediated RNA Decay Based Conditions and Diseases." This application discusses how alternative splicing events in genes can lead to non-productive mRNA transcripts, resulting in aberrant protein expression. The therapeutic agents he proposes aim to target these splicing events to modulate the expression levels of functional proteins in patients, potentially treating conditions caused by protein deficiency.
Another significant application is "Methods and Compositions for Modulating Splicing and Translation." This application also addresses the impact of alternative splicing on mRNA transcripts and proposes therapeutic agents that can modulate the expression levels of functional proteins. The methods outlined aim to treat diseases caused by a deficient amount or activity of a functional target protein by modulating splicing of pre-mRNA.
Conclusion: Juergen Scharner is a dedicated inventor making strides in RNA therapeutics at Stoke Therapeutics, Inc. His latest patent applications reflect his commitment to addressing critical health challenges through innovative research.